TY - JOUR
T1 - Expression of multidrug resistance 1 and Glutathione-S-Transferase-π protein in nasopharyngeal carcinoma
AU - Chen, Chi Long
AU - Sheen, Tzung Shiahn
AU - Lou, Ia Uen
AU - Huang, Ai Chun
N1 - Funding Information:
Supported by a grant from the National Science Council, Taiwan (NSC83-0412-B002-020), and a grant from the National Health Research Institute, Taiwan (DOH87-HR-708).
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2001
Y1 - 2001
N2 - Radiotherapy is the modality of choice for the treatment of nasopharyngeal carcinoma (NPC). However, systemic chemotherapy has recently been found to play an increasing role in the treatment of advanced or metastatic disease. The status of drug resistance gene expression that has crucial impact on chemotherapy has not been fully addressed for patients with NPC. In this study, we examined the expression of multidrug resistance 1 (MDR-1) and glutathione-Stransferase-π (GST-π) in primary, recurrent, and metastatic NPC using results of immunohistochemical examinations. The results were correlated with the expression of Epstein-Barr virus (EBV) latent protein, latent membrane protein 1 (LMP1), and clinicopathologic features, including stage, histopathologic types, and survival rates. MDR-1 protein expression was detected in 18 (12.6%) of 143 patients with primary NPC, 14 (32.6%) of 43 with recurrent NPC, and O (0%) of 20 with metastatic NPC, whereas 83 (58%) of 143 patients with primary NPC, 30 (69.8%) of 43 with recurrent NPC, and 13 (65%) of 20 with metastatic NPC expressed GST-π. EBV-LMP1 was expressed in 59 (41.3%) of 143 patients with primary NPC, 23 (53.5%) of 43 with recurrent NPC, and 9 (45%) of 20 with metastatic NPC. Simultaneous expression of MDR1 and GST-π was observed in 13 (72.2%) of 18 patients with primary NPC and 12 (85.7%) of 14 with recurrent NPC. The expression of LMP1 was detected in only 6 of the 13 patients with primary NPC and 6 of the 12 with recurrent NPC. We concluded that the expression of GST-π was more frequent in NPC tumor tissues than the expression of MDR-1. The expression of MDR-1 correlated with clinicopathologic features of primary NPC, including the histopathologic types and survival rates, but not with disease stage. The expression of GST-π did not correlate with clinicopathologic features. The expression of MDR-1 and GST-π did not correlate with expression of EBV-LMP1 for patients with NPC.
AB - Radiotherapy is the modality of choice for the treatment of nasopharyngeal carcinoma (NPC). However, systemic chemotherapy has recently been found to play an increasing role in the treatment of advanced or metastatic disease. The status of drug resistance gene expression that has crucial impact on chemotherapy has not been fully addressed for patients with NPC. In this study, we examined the expression of multidrug resistance 1 (MDR-1) and glutathione-Stransferase-π (GST-π) in primary, recurrent, and metastatic NPC using results of immunohistochemical examinations. The results were correlated with the expression of Epstein-Barr virus (EBV) latent protein, latent membrane protein 1 (LMP1), and clinicopathologic features, including stage, histopathologic types, and survival rates. MDR-1 protein expression was detected in 18 (12.6%) of 143 patients with primary NPC, 14 (32.6%) of 43 with recurrent NPC, and O (0%) of 20 with metastatic NPC, whereas 83 (58%) of 143 patients with primary NPC, 30 (69.8%) of 43 with recurrent NPC, and 13 (65%) of 20 with metastatic NPC expressed GST-π. EBV-LMP1 was expressed in 59 (41.3%) of 143 patients with primary NPC, 23 (53.5%) of 43 with recurrent NPC, and 9 (45%) of 20 with metastatic NPC. Simultaneous expression of MDR1 and GST-π was observed in 13 (72.2%) of 18 patients with primary NPC and 12 (85.7%) of 14 with recurrent NPC. The expression of LMP1 was detected in only 6 of the 13 patients with primary NPC and 6 of the 12 with recurrent NPC. We concluded that the expression of GST-π was more frequent in NPC tumor tissues than the expression of MDR-1. The expression of MDR-1 correlated with clinicopathologic features of primary NPC, including the histopathologic types and survival rates, but not with disease stage. The expression of GST-π did not correlate with clinicopathologic features. The expression of MDR-1 and GST-π did not correlate with expression of EBV-LMP1 for patients with NPC.
KW - Epstein-Barr virus
KW - Glutathione-S-transferase-π
KW - Latent membrane protein 1
KW - Multidrug resistance 1
KW - Nasopharyngeal carcinoma
UR - http://www.scopus.com/inward/record.url?scp=0035190727&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035190727&partnerID=8YFLogxK
U2 - 10.1053/hupa.2001.28950
DO - 10.1053/hupa.2001.28950
M3 - Article
C2 - 11727264
AN - SCOPUS:0035190727
SN - 0046-8177
VL - 32
SP - 1240
EP - 1244
JO - Human Pathology
JF - Human Pathology
IS - 11
ER -